About
Neurotech solutions is a digital health company focused on eliminating undiagnosed ADHD. The companys mission is to help every person with ADHD lead a better life and fulfill their potential. Neurotech Solutions core technology is a cloud-based, AI-driven online test that looks and feels like a game. The technology was first implemented in a clinical product called MOXO d-CPT, a decision-support tool for the diagnosis of ADHD. Using MOXO d-CPT, a healthcare professional can obtain objective, standardized, comparative results about a patients attentional difficulties in just 14 to 18 minutes. More than 500,000 MOXO tests have been performed to date in over 20 countries. During the COVID-19 pandemic, the company released a home version of MOXO to enable a full remote and objective diagnosis of ADHD. The companys core technology was also implemented in an educational product called AXON-School. Intended for all K-12 children, the product objectively highlights children with attentional difficulties and suggests educational strategies for personalized learning. Neurotech Solutions opened a subsidiary in Guangzhou, China, in 2021.
Funding history · 2 rounds · $3.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Neurotech Solutions' primary focus?
- Neurotech Solutions is a digital health company focused on eliminating undiagnosed ADHD.
- What is Neurotech Solutions' core technology?
- Neurotech Solutions' core technology is a cloud-based, AI-driven online test designed for ADHD diagnosis.
- What is MOXO d-CPT and its purpose?
- MOXO d-CPT is a clinical product from Neurotech Solutions that serves as a decision-support tool for the diagnosis of ADHD.
- How many MOXO tests have been performed to date?
- More than 500,000 MOXO tests have been performed to date in over 20 countries.
- What product did Neurotech Solutions release during the COVID-19 pandemic?
- During the COVID-19 pandemic, Neurotech Solutions released a home version of MOXO to enable remote and objective ADHD diagnosis.
- What is AXON-School?
- AXON-School is an educational product by Neurotech Solutions for K-12 children that identifies attentional difficulties and suggests personalized learning strategies.
- When and where did Neurotech Solutions open a subsidiary?
- Neurotech Solutions opened a subsidiary in Guangzhou, China, in 2021.
- What was Neurotech Solutions' last recorded funding round?
- In March 2018, Neurotech Solutions secured an undisclosed funding round of $3.5 million, with Guangzhou Sino-Israel Biotech Investment Fund (GIBF) as a lead investor. For full financing history, refer to startupim.
- How many employees does Neurotech Solutions have?
- Neurotech Solutions has between 11 and 50 employees.